Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nu Skin Enterprises reports $2.23B revenue for 2022, focuses on innovation and social commerce

Nu Skin Enterprises navigated challenges in 2022, focusing on innovation and social commerce to drive revenue growth. The company aims to overcome challenges in 2023 and achieve Nu Vision 2025 goals through strategic initiatives. Nu Skin's emphasis on enhancing the iO experience and optimizing expenses positions it for sustainable value to investors.

Nu Skin Enterprises meets Q1 expectations, eyes growth in Asia

Nu Skin's Q1 performance in line with expectations, with notable success in key markets like South Korea and Mainland China.
Challenges persist in certain regions due to macroeconomic factors, necessitating strategic adjustments for sustained growth.
Opportunities lie in expanding TRMe program, leveraging digital initiatives, and driving operational improvements for long-term value creation.

Nu Skin reports robust Q2 earnings, eyes growth through acquisitions

Nu Skin Enterprises delivered strong Q2 results driven by Mainland China growth, with revenue of $500.3 million and EPS of $0.54. The company faces challenges in other markets due to macro-related pressures.
Strategic acquisitions of BeautyBio and LifeDNA aim to enhance Nu Skin's core business through personalization and technology. The company's focus on innovation and market trends presents growth opportunities.
With a clear strategic direction, Nu Skin is poised to navigate challenges, capitalize on opportunities, and drive continued growth in the beauty and wellness industry.

Nu Skin reports Q3 revenue of $499M, adjusts 2023 guidance

Nu Skin adjusts 2023 guidance, expecting revenue of $1.92B to $1.96B and EPS of negative $0.10 to $0.05. The company is streamlining expenses and maximizing cash flow.

Nu Skin surpasses Q4 revenue targets, eyes growth opportunities

Nu Skin Enterprises delivered strong Q4 results, exceeding revenue guidance and showcasing a focus on innovation and strategic growth initiatives.
Despite challenges in certain regions, the company demonstrated resilience and stability in key markets, laying the groundwork for future expansion and market penetration.
By rebalancing dividends for growth investments and prioritizing reinvestment in the business, Nu Skin is poised to capitalize on opportunities for market diversification and sustainable growth.
With a clear roadmap for 2024, including product launches, market entries, and capital reallocation strategies, Nu Skin is well-positioned to drive performance and enhance shareholder value.

Nu Skin Enterprises reports robust Q1 earnings, eyes global expansion

Nu Skin Enterprises showcased resilience in revenue and earnings, driven by strong performance in core and new business segments.
While facing challenges from macroeconomic factors, the company is strategically focused on innovation, cost efficiency, and market expansion.
Opportunities lie in product diversification, market entries, and sustainability efforts, positioning Nu Skin for future growth and market leadership.

Nu Skin surpasses Q2 revenue targets, eyes growth amid challenges

Nu Skin Enterprises delivered strong Q2 performance, exceeding revenue guidance and showcasing financial discipline. Despite challenges in China and FX pressures, the company remains focused on innovation and growth. Strategic investments in new products, markets, and brand awareness position Nu Skin for future success. Revised guidance reflects adaptability to market conditions and commitment to long-term vision.

Nu Skin Enterprises meets Q3 guidance, eyes India expansion

Nu Skin's Q3 performance reflects a balanced approach to addressing challenges and leveraging strengths.
Strategic initiatives to drive growth, optimize operations, and expand into new markets are key focus areas.
Despite market pressures, Nu Skin's focus on innovation and efficiency bodes well for future growth.
Overall, Nu Skin's financials and strategic direction indicate a resilient and forward-thinking company.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Helen of Troy

NUS vs. HELE: Which Stock Is the Better Value Option?

NUS vs. HELE: Which Stock Should Value Investors Buy Now?

Bull of the Day: Nu Skin (NUS)

ABM Industries

AutoNation

BMC Stock Hlds

Mr. Cooper Group Inc

DaVita

Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have higher chances of carrying the momentum forward.

6 Stocks Trading Near 52-Week Highs That Can Rally Further

Nu Skin's (NUS) second-quarter 2020 results reflect lower earnings and sales. Nevertheless, management raises 2020 view on better than expected year-to-date performance.

Nu Skin's (NUS) Q2 Earnings Beat Estimates, Sales Decline Y/Y

Nu Skin Enterprises' (NUS) CEO Ritch Wood on Q2 2020 Results - Earnings Call Transcript

PROVO, Utah, Aug. 5, 2020 /PRNewswire/ -- Nu Skin Enterprises, Inc.

Nu Skin Enterprises Reports Second-Quarter 2020 Results And Raises 2020 Guidance

Energizer Holdings

Flowers Foods

Newell Brands

Ollie's Bargain Outlet Hlds

Amid coronavirus crisis, players in the Consumer Staples sector are gaining from rising demand on stockpiling. We bring five stocks with earnings beat potential.

5 Consumer Staples Stocks to Beat on Earnings Amid Coronavirus

B&G Foods

Medifast

Monster Beverage

The consumer staples sector has so far reported relatively better results despite the decline of overall sector's earnings year over year.

Top 5 Consumer Staple Stocks Ahead of Q2 Earnings Results

Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

D.R. Horton

Meritage Homes

PulteGroup

Silgan Hlds

At this stage, it would be prudent to pick up value stocks with a favorable Zacks Rank that popped in July and still have momentum.

5 Top-Ranked Value Stocks With Double-Digit Returns in July

Bonanza Creek Energy

TopBuild

Noble Energy

Although earnings growth is negative year over year, a handful of growth stocks with a favorable Zacks Rank are set to beat Q2 earnings estimates.

5 Must-Buy Growth Stocks Set to Beat Q2 Earnings Estimates

Cisco Systems

FleetCor Technologies

Rockwell Automation

When brokers upgrade a stock, you can rely on their judgment. Nonetheless, you should also take into account some other factors to ensure steady returns.

5 Top-Ranked Stocks With Upgraded Broker Ratings to Buy Now

Clorox

Kellogg

Nomad Foods

We have picked five consumer staple stocks, which are likely to report earnings beat this season owing to the burgeoning demand amid the pandemic-led increased at-home consumption.

5 Consumer Staple Stocks to Buy With Earnings Beat Potential

NUS is attractively exposed to China and the ASEAN regions where growth prospects look more promising.

Nu Skin Enterprises: A Lot Going For It

Nu Skin Enterprises, Inc. (NUS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: Nu Skin Enterprises

As of late, it has definitely been a great time to be an investor of Nu Skin Enterprises

Will Nu Skin Continue to Surge Higher?

The company substantially boosted an important estimate.

Why Shares of Nu Skin Enterprises Are Crushing the Market Today

Nu Skin (NUS) witnesses robust consumer growth during second-quarter 2020. The company raises sales guidance for the quarter.

Nu Skin (NUS) Revises Q2 Sales View Upward, Stock Rises

Shares of Nu Skin Enterprises Inc. NUS, +0.57% jumped more than 11% in the extended session Wednesday after the maker of supplements and personal care products estimated that its second-quarter sales will be between $603 million and $608 million, above its previous forecast.

Nu Skin stock rallies 11% after company's better Q2 sales outlook

PROVO, Utah, July 1, 2020 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today reported it estimates revenue for the second quarter of 2020 to be approximately $603 to $608 million. The company previously forecasted second-quarter revenue of $520 to $550 million. The company will...

Nu Skin Enterprises Reports Estimated Second-Quarter Revenue Above Previous Guidance

United Natural Foods

Consumer staples sector shows resilience amid the pandemic due to strong demand for food and other essentials. Efforts to keep pace with consumer trends should bolster the sector's growth.

Tap Market Potential With These 4 Consumer Staples Stocks

Nu Skin (NUS) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Why Nu Skin (NUS) Could Be a Top Value Stock Pick

Kimberly-Clark

At a juncture where many companies have suspended dividends due to the coronavirus crisis, we have picked five consumer staple stocks, which are continuing with dividend payments.

5 Consumer Staple Dividend Stocks to Enrich Your Portfolio

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Nu Skin (NUS) Up 11.9% Since Last Earnings Report: Can It Continue?

Nu Skin (NUS) has been seeing improved trends in Mainland China as coronavirus-induced restrictions are being lifted in the region.

News for Nu Skin Enterprises Stock (NUS)